BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 16195977)

  • 1. [Matrix metalloproteinases and their role in menstruation and endometriosis].
    Hudelist G; Singer CF; Keckstein J
    Zentralbl Gynakol; 2005 Oct; 127(5):320-4. PubMed ID: 16195977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of matrix metalloproteinases in the pathogenesis of endometriosis.
    Pitsos M; Kanakas N
    Reprod Sci; 2009 Aug; 16(8):717-26. PubMed ID: 19351962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and endometriosis.
    Osteen KG; Yeaman GR; Bruner-Tran KL
    Semin Reprod Med; 2003 May; 21(2):155-64. PubMed ID: 12917785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis.
    Osteen KG; Bruner-Tran KL; Keller NR; Eisenberg E
    Ann N Y Acad Sci; 2002 Mar; 955():37-47; discussion 86-8, 396-406. PubMed ID: 11949963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracrine regulation of endometriotic tissue.
    Minici F; Tiberi F; Tropea A; Miceli F; Orlando M; Gangale MF; Romani F; Catino S; Campo S; Lanzone A; Apa R
    Gynecol Endocrinol; 2007 Oct; 23(10):574-80. PubMed ID: 17952762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endometrium in endometriosis.
    Ulukus M; Cakmak H; Arici A
    J Soc Gynecol Investig; 2006 Oct; 13(7):467-76. PubMed ID: 16990031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis.
    Osteen KG; Bruner-Tran KL; Eisenberg E
    Fertil Steril; 2005 Mar; 83(3):529-37. PubMed ID: 15749474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of endometriosis.
    Nap AW; Groothuis PG; Demir AY; Evers JL; Dunselman GA
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):233-44. PubMed ID: 15157640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model.
    Nap AW; Dunselman GA; de Goeij AF; Evers JL; Groothuis PG
    Hum Reprod; 2004 Oct; 19(10):2180-7. PubMed ID: 15242997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2.
    Uzan C; Cortez A; Dufournet C; Fauvet R; Siffroi JP; Daraï E
    Virchows Arch; 2004 Dec; 445(6):603-9. PubMed ID: 15452706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine regulation of matrix metalloproteinase expression in endometriosis.
    Sharpe-Timms KL; Cox KE
    Ann N Y Acad Sci; 2002 Mar; 955():147-56; discussion 157-8, 396-406. PubMed ID: 11949944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the cadherin subtypes present in the human peritoneum and endometriotic lesions: potential role for P-cadherin in the development of endometriosis.
    Chen GT; Tai CT; Yeh LS; Yang TC; Tsai HD
    Mol Reprod Dev; 2002 Jul; 62(3):289-94. PubMed ID: 12112590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis.
    Osteen KG; Bruner-Tran KL; Ong D; Eisenberg E
    Ann N Y Acad Sci; 2002 Mar; 955():139-46; discussion 157-8, 396-406. PubMed ID: 11949943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometriosis: interaction of immune and endocrine systems.
    Seli E; Arici A
    Semin Reprod Med; 2003 May; 21(2):135-44. PubMed ID: 12917783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review).
    Bałkowiec M; Maksym RB; Włodarski PK
    Mol Med Rep; 2018 Sep; 18(3):3123-3136. PubMed ID: 30066912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of focal adhesion kinase expression in eutopic endometrium of women with endometriosis.
    Mu L; Zheng W; Wang L; Chen XJ; Zhang X; Yang JH
    Fertil Steril; 2008 Mar; 89(3):529-37. PubMed ID: 17543958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attachment to extracellular matrices is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis.
    Adachi M; Nasu K; Tsuno A; Yuge A; Kawano Y; Narahara H
    Eur J Obstet Gynecol Reprod Biol; 2011 Mar; 155(1):85-8. PubMed ID: 21112686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis.
    Hudelist G; Keckstein J; Czerwenka K; Lass H; Walter I; Auer M; Wieser F; Wenzl R; Kubista E; Singer CF
    Fertil Steril; 2005 Oct; 84 Suppl 2():1249-56. PubMed ID: 16210018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.